Eaton Vance Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$30M Buy
112,246
+1,310
+1% +$350K 0.04% 360
2022
Q2
$22.6M Sell
110,936
-3,936
-3% -$803K 0.03% 433
2022
Q1
$24.2M Sell
114,872
-19,582
-15% -$4.12M 0.03% 461
2021
Q4
$32.3M Sell
134,454
-6,995
-5% -$1.68M 0.04% 383
2021
Q3
$39.5M Sell
141,449
-22,065
-13% -$6.17M 0.06% 306
2021
Q2
$56.6M Buy
163,514
+26
+0% +$9K 0.08% 244
2021
Q1
$45.7M Buy
163,488
+1,444
+0.9% +$404K 0.07% 278
2020
Q4
$39.7M Buy
162,044
+8,802
+6% +$2.16M 0.06% 284
2020
Q3
$43.5M Sell
153,242
-15,254
-9% -$4.33M 0.08% 230
2020
Q2
$45.1M Sell
168,496
-5,174
-3% -$1.38M 0.09% 204
2020
Q1
$54.9M Buy
173,670
+1,340
+0.8% +$424K 0.13% 147
2019
Q4
$51.1M Buy
172,330
+1,410
+0.8% +$418K 0.1% 194
2019
Q3
$39.8M Sell
170,920
-130,783
-43% -$30.4M 0.09% 208
2019
Q2
$70.6M Sell
301,703
-6,273
-2% -$1.47M 0.15% 145
2019
Q1
$72.8M Sell
307,976
-59,556
-16% -$14.1M 0.17% 135
2018
Q4
$111M Sell
367,532
-81,109
-18% -$24.4M 0.29% 93
2018
Q3
$159M Buy
448,641
+52
+0% +$18.4K 0.35% 84
2018
Q2
$130M Sell
448,589
-296,205
-40% -$86M 0.31% 92
2018
Q1
$204M Buy
744,794
+316,192
+74% +$86.6M 0.25% 106
2017
Q4
$137M Sell
428,602
-19,771
-4% -$6.3M 0.33% 85
2017
Q3
$140M Buy
448,373
+12,065
+3% +$3.78M 0.36% 80
2017
Q2
$118M Sell
436,308
-24,032
-5% -$6.52M 0.31% 91
2017
Q1
$126M Sell
460,340
-240,551
-34% -$65.8M 0.34% 84
2016
Q4
$199M Buy
700,891
+205,238
+41% +$58.2M 0.56% 48
2016
Q3
$155M Buy
495,653
+60,033
+14% +$18.8M 0.45% 65
2016
Q2
$105M Buy
435,620
+309,401
+245% +$74.8M 0.31% 94
2016
Q1
$32.9M Sell
126,219
-3,818
-3% -$994K 0.1% 165
2015
Q4
$39.8M Sell
130,037
-198,751
-60% -$60.9M 0.12% 157
2015
Q3
$95.9M Sell
328,788
-187,746
-36% -$54.8M 0.3% 90
2015
Q2
$209M Buy
516,534
+71,929
+16% +$29.1M 0.64% 42
2015
Q1
$188M Buy
444,605
+40,320
+10% +$17M 0.57% 55
2014
Q4
$137M Sell
404,285
-59,394
-13% -$20.2M 0.4% 76
2014
Q3
$153M Buy
463,679
+64,887
+16% +$21.5M 0.46% 68
2014
Q2
$126M Buy
398,792
+73,864
+23% +$23.3M 0.37% 80
2014
Q1
$99.4M Buy
324,928
+112,901
+53% +$34.5M 0.29% 98
2013
Q4
$59.3M Buy
212,027
+103,909
+96% +$29.1M 0.17% 137
2013
Q3
$26M Buy
108,118
+47,289
+78% +$11.4M 0.08% 180
2013
Q2
$13.1M Buy
+60,829
New +$13.1M 0.04% 243